LT3348546T - Androgeno receptorių inhibitoriaus kristalinė forma ir jos gavimo būdas - Google Patents
Androgeno receptorių inhibitoriaus kristalinė forma ir jos gavimo būdasInfo
- Publication number
- LT3348546T LT3348546T LTEP16843560.0T LT16843560T LT3348546T LT 3348546 T LT3348546 T LT 3348546T LT 16843560 T LT16843560 T LT 16843560T LT 3348546 T LT3348546 T LT 3348546T
- Authority
- LT
- Lithuania
- Prior art keywords
- preparation
- crystalline form
- androgen receptor
- receptor inhibitor
- inhibitor
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/86—Oxygen and sulfur atoms, e.g. thiohydantoin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4166—1,3-Diazoles having oxo groups directly attached to the heterocyclic ring, e.g. phenytoin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510574141 | 2015-09-10 | ||
| CN201610073458 | 2016-02-02 | ||
| PCT/CN2016/096381 WO2017041622A1 (zh) | 2015-09-10 | 2016-08-23 | 一种雄性激素受体抑制剂的结晶形式及其制备方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| LT3348546T true LT3348546T (lt) | 2020-07-27 |
Family
ID=58240573
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| LTEP16843560.0T LT3348546T (lt) | 2015-09-10 | 2016-08-23 | Androgeno receptorių inhibitoriaus kristalinė forma ir jos gavimo būdas |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US10150739B2 (lt) |
| EP (1) | EP3348546B1 (lt) |
| JP (1) | JP6843116B2 (lt) |
| KR (1) | KR20180048939A (lt) |
| CN (1) | CN107001284B (lt) |
| AU (1) | AU2016318700B2 (lt) |
| BR (1) | BR112018003258A2 (lt) |
| CA (1) | CA2996674A1 (lt) |
| CY (1) | CY1123027T1 (lt) |
| DK (1) | DK3348546T3 (lt) |
| ES (1) | ES2794568T3 (lt) |
| HR (1) | HRP20200852T1 (lt) |
| HU (1) | HUE050459T2 (lt) |
| LT (1) | LT3348546T (lt) |
| MX (1) | MX2018002759A (lt) |
| PL (1) | PL3348546T3 (lt) |
| PT (1) | PT3348546T (lt) |
| RS (1) | RS60448B1 (lt) |
| RU (1) | RU2018109121A (lt) |
| SI (1) | SI3348546T1 (lt) |
| TW (1) | TWI708764B (lt) |
| WO (1) | WO2017041622A1 (lt) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107001284B (zh) | 2015-09-10 | 2019-11-22 | 江苏恒瑞医药股份有限公司 | 一种雄性激素受体抑制剂的结晶形式及其制备方法 |
| CN112300076B (zh) * | 2017-12-13 | 2022-10-25 | 江苏恒瑞医药股份有限公司 | 一种雄性激素受体抑制剂的晶型及其制备方法 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2006028226A1 (ja) * | 2004-09-09 | 2006-03-16 | Chugai Seiyaku Kabushiki Kaisha | 新規イミダゾリジン誘導体およびその用途 |
| PT2444085E (pt) | 2005-05-13 | 2015-06-11 | Univ California | Compostos de diaril-hidantoínas como antagonistas do recetor androgénio para tratamento de cancro |
| EP2416657A4 (en) * | 2009-04-09 | 2012-09-05 | Medivation Prostate Therapeutics Inc | COMPOUNDS COMPRISING SUBSTITUTED DI-ARYLHYDANTOIDS AND DI-ARYLTHIOHYDANTOINES AND METHODS OF USE THEREOF |
| DK2894151T3 (da) * | 2012-09-04 | 2021-01-11 | Shanghai hengrui pharmaceutical co ltd | Imidazolinderivater, fremgangsmåder til fremstilling deraf og anvendelse deraf i medicin |
| CA2884640A1 (en) * | 2012-09-11 | 2014-03-20 | Dr. Reddy's Laboratories Limited | Enzalutamide polymorphic forms and its preparation |
| CN104356068A (zh) * | 2014-10-30 | 2015-02-18 | 杭州新博思生物医药有限公司 | 恩杂鲁胺新晶型及其制备方法 |
| CN107001284B (zh) | 2015-09-10 | 2019-11-22 | 江苏恒瑞医药股份有限公司 | 一种雄性激素受体抑制剂的结晶形式及其制备方法 |
-
2016
- 2016-08-23 CN CN201680003850.4A patent/CN107001284B/zh active Active
- 2016-08-23 SI SI201630801T patent/SI3348546T1/sl unknown
- 2016-08-23 WO PCT/CN2016/096381 patent/WO2017041622A1/zh active Application Filing
- 2016-08-23 KR KR1020187009184A patent/KR20180048939A/ko not_active Application Discontinuation
- 2016-08-23 LT LTEP16843560.0T patent/LT3348546T/lt unknown
- 2016-08-23 CA CA2996674A patent/CA2996674A1/en active Pending
- 2016-08-23 JP JP2018508712A patent/JP6843116B2/ja active Active
- 2016-08-23 EP EP16843560.0A patent/EP3348546B1/en active Active
- 2016-08-23 PT PT168435600T patent/PT3348546T/pt unknown
- 2016-08-23 PL PL16843560T patent/PL3348546T3/pl unknown
- 2016-08-23 RS RS20200617A patent/RS60448B1/sr unknown
- 2016-08-23 MX MX2018002759A patent/MX2018002759A/es unknown
- 2016-08-23 ES ES16843560T patent/ES2794568T3/es active Active
- 2016-08-23 AU AU2016318700A patent/AU2016318700B2/en not_active Ceased
- 2016-08-23 US US15/757,652 patent/US10150739B2/en active Active
- 2016-08-23 RU RU2018109121A patent/RU2018109121A/ru unknown
- 2016-08-23 BR BR112018003258-1A patent/BR112018003258A2/pt not_active Application Discontinuation
- 2016-08-23 HU HUE16843560A patent/HUE050459T2/hu unknown
- 2016-08-23 DK DK16843560.0T patent/DK3348546T3/da active
- 2016-09-07 TW TW105128891A patent/TWI708764B/zh active
-
2020
- 2020-05-26 HR HRP20200852TT patent/HRP20200852T1/hr unknown
- 2020-06-09 CY CY20201100522T patent/CY1123027T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| RU2018109121A3 (lt) | 2019-12-04 |
| SI3348546T1 (sl) | 2020-09-30 |
| EP3348546A1 (en) | 2018-07-18 |
| RU2018109121A (ru) | 2019-10-10 |
| TW201713628A (zh) | 2017-04-16 |
| US20180244628A1 (en) | 2018-08-30 |
| JP2018526364A (ja) | 2018-09-13 |
| CA2996674A1 (en) | 2017-03-16 |
| US10150739B2 (en) | 2018-12-11 |
| KR20180048939A (ko) | 2018-05-10 |
| WO2017041622A1 (zh) | 2017-03-16 |
| PL3348546T3 (pl) | 2020-09-21 |
| BR112018003258A2 (pt) | 2018-09-25 |
| PT3348546T (pt) | 2020-05-29 |
| MX2018002759A (es) | 2018-08-01 |
| HRP20200852T1 (hr) | 2020-08-21 |
| CY1123027T1 (el) | 2021-10-29 |
| TWI708764B (zh) | 2020-11-01 |
| CN107001284B (zh) | 2019-11-22 |
| ES2794568T3 (es) | 2020-11-18 |
| EP3348546A4 (en) | 2019-03-27 |
| AU2016318700A1 (en) | 2018-04-05 |
| DK3348546T3 (da) | 2020-07-06 |
| HUE050459T2 (hu) | 2020-12-28 |
| AU2016318700B2 (en) | 2020-05-07 |
| RS60448B1 (sr) | 2020-07-31 |
| CN107001284A (zh) | 2017-08-01 |
| JP6843116B2 (ja) | 2021-03-17 |
| EP3348546B1 (en) | 2020-04-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL255738A (en) | A new crystalline form of lenbatinib mesylate and a process for its preparation | |
| GB201514756D0 (en) | Compound and method of use | |
| IL284005A (en) | Glucocorticoid receptor inhibitors | |
| GB201514760D0 (en) | Compounds and method of use | |
| SI3380554T1 (sl) | Kristalne oblike per-kloro-gama-ciklodekstrinov | |
| HK1256860A1 (zh) | 喹唑啉衍生物的晶體及其製備方法 | |
| HK1244274A1 (zh) | C21h22ci2n4o2的晶型 | |
| IL253186B (en) | A new crystalline form of a benzaimidazole derivative and a method for its preparation | |
| PL3327012T3 (pl) | Krystaliczne postacie bilastyny i sposoby ich wytwarzania | |
| HK1252057A1 (zh) | 新穎的使用方法和組合物 | |
| IL253479A0 (en) | Crystalline forms of efinconazole | |
| HK1258438A1 (zh) | 2-巰基苯並噻唑的製備方法 | |
| PT3539545T (pt) | Forma cristalina de antagonista do recetor de gnrh e método para a preparação da mesma | |
| IL270961A (en) | Crystalline form of N-butyldeoxygalactonogirimycin | |
| SI3348546T1 (sl) | Kristalinična oblika zaviralca androgenega receptorja in postopek priprave le-tega | |
| HK1252375A1 (zh) | 喹唑啉衍生物的晶體及其製備方法 | |
| IL254597A0 (en) | Crystalline form of ahu377, method for its preparation and use | |
| IL270937A (en) | Crystalline forms of saltalicib |